The pathogenesis and genetics of psoriasis;Psoriasis: bases genéticas y patogenéticas

Actas Dermo-Sifiliograficas

Volumn 105, Issue 6, 2014, Pages 535-545

  Puig, L ^a   Julia A ^b   Marsal, S ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Genetics; Pathogenesis; Psoriasis; Psoriatic arthritis

Indexed keywords

ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; DISEASE CLASSIFICATION; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INNATE IMMUNITY; PATHOGENESIS; PROGNOSIS; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; REVIEW; SIGNAL TRANSDUCTION; SKIN; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY;

GENOME-WIDE ASSOCIATION STUDY; HUMANS; PSORIASIS;

EID: 84903581218     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2014.05.013     Document Type: Short Survey

References (76)

1. K. Asumalahti, M. Ameen, S. Suomela, E. Hagforsen, G. Michaelsson, and J. Evans et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis J Invest Dermatol 120 2003 627 632
2. J.E. Gudjonsson, A. Karason, A. Antonsdottir, E.H. Runarsdottir, V.B. Hauksson, and R. Upmanyu et al. Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes Br J Dermatol 148 2003 233 235
3. A.M. Bowcock, and W.O. Cookson The genetics of psoriasis, psoriatic arthritis and atopic dermatitis Hum Mol Genet 13 Spec No 1 2004 R43 R55
4. B.J. Nickoloff, J.Z. Qin, and F.O. Nestle Immunopathogenesis of psoriasis Clin Rev Allergy Immunol 33 2007 45 56
5. M.A. Lowes, A.M. Bowcock, and J.G. Krueger Pathogenesis and therapy of psoriasis Nature 445 2007 866 873
6. A.S. Buchau, and R.L. Gallo Innate immunity and antimicrobial defense systems in psoriasis Clin Dermatol 25 2007 616 624
7. C.N. Ellis, D.C. Gorsulowsky, T.A. Hamilton, J.K. Billings, M.D. Brown, and J.T. Headington et al. Cyclosporine improves psoriasis in a double-blind study JAMA 256 1986 3110 3116
8. S.L. Gottlieb, P. Gilleaudeau, R. Johnson, L. Estes, T.G. Woodworth, and A.B. Gottlieb et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis Nat Med 1 1995 442 447
9. A.B. Gottlieb, M. Lebwohl, S. Shirin, A. Sherr, P. Gilleaudeau, and G. Singer et al. Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study J Am Acad Dermatol 43 2000 595 604
10. J.R. Abrams, S.L. Kelley, E. Hayes, T. Kikuchi, M.J. Brown, and S. Kang et al. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells J Exp Med 192 2000 681 694
11. L.H. Kircik, and J.Q. del Rosso Anti-TNF agents for the treatment of psoriasis J Drugs Dermatol 8 2009 546 559
12. J.M. Benson, C.W. Sachs, G. Treacy, H. Zhou, C.E. Pendley, and C.M. Brodmerkel et al. Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab Nat Biotechnol 29 2011 615 624
13. O. Boyman, H.P. Hefti, C. Conrad, B.J. Nickoloff, M. Suter, and F.O. Nestle Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha J Exp Med 199 2004 731 736
14. C. Conrad, O. Boyman, G. Tonel, A. Tun-Kyi, U. Laggner, and A. de Fougerolles et al. Alpha1 beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis Nat Med 13 2007 836 842
15. L. Steinman A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage Nat Med 13 2007 139 145
16. I. Kryczek, A.T. Bruce, J.E. Gudjonsson, A. Johnston, L. Vatan, and W. Szeliga et al. Induction of memory IL-17+ T cell trafficking and expansion by IFN-gamma: mechanism and pathological relevance J Immunol 181 2008 4733 4741
17. K.E. Nograles, L.C. Zaba, A. Shemer, J. Fuentes-Duculan, I. Cardinale, and T. Kikuchi et al. IL-22-producing «T22» T cells account for upregulated IL22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells J Allergy Clin Immunol 123 2009 1244 1252
18. F. Capon, R.C. Trembath, and J.N. Barker An update on the genetics of psoriasis Dermatol Clin 22 2004 339 347
19. H. Valdimarsson, A. Karason, and J.E. Gudjonsson Psoriasis: a complex clinical and genetic disorder Curr Rheumatol Rep 6 2004 314 316
20. M. Allen, H. Ameen, C. Veal, J. Evans, V.S. Ramrakha-Jones, and A.M. Marsland et al. The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis J Invest Dermatol 124 2005 103 106
21. H. Valdimarsson The genetic basis of psoriasis Clin Dermatol 25 2007 563 567
22. L.D. Sun, S. Yang, J.J. Liu, Y.Q. Ren, X. Fan, and S.X. Xu et al. Follow-up analysis of 180 Chinese Han families: identification of a novel locus for psoriasis at 2p22.3-11.2 Br J Dermatol 158 2008 512 517
23. R.P. Nair, P.E. Stuart, I. Nistor, R. Hiremagalore, N.V. Chia, and S. Jenisch et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene Am J Hum Genet 78 2006 827 851
24. X. Fan, S. Yang, W. Huang, Z.M. Wang, L.D. Sun, and Y.H. Liang et al. Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population PLoS Genet 4 2008 e1000038
25. K.C. Duffin, and G.G. Krueger Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association J Invest Dermatol 129 2009 827 833
26. J.T. Elder, A.T. Bruce, J.E. Gudjonsson, A. Johnston, P.E. Stuart, and T. Tejasvi et al. Molecular dissection of psoriasis: integrating genetics and biology J Invest Dermatol 130 2010 1213 1226
27. M. Cargill, S.J. Schrodi, M. Chang, V.E. Garcia, R. Brandon, and K.P. Callis et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes Am J Hum Genet 80 2007 273 290
28. R.P. Nair, K.C. Duffin, C. Helms, J. Ding, P.E. Stuart, D. Goldgar Collaborative Association Study of Psoriasis Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways Nat Genet 41 2009 199 204
29. F. Capon, M.P. Di, J. Szaub, N.J. Prescott, C. Dunster, and L. Baumber et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis Hum Genet 122 2007 201 206
30. R.L. Smith, R.B. Warren, S. Eyre, P. Ho, X. Ke, and H.S. Young et al. Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort J Invest Dermatol 128 2008 1325 1327
31. R.P. Nair, A. Ruether, P.E. Stuart, S. Jenisch, T. Tejasvi, and R. Hiremagalore et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis J Invest Dermatol 128 2008 1653 1661
32. U. Huffmeier, J. Lascorz, B. Bohm, J. Lohmann, J. Wendler, and R. Mossner et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis J Invest Dermatol 129 2009 355 358
33. J. Bowes, and A. Barton The genetics of psoriatic arthritis: lessons from genome-wide association studies Discov Med 10 2010 177 183
34. Y. Liu, C. Helms, W. Liao, L.C. Zaba, S. Duan, and J. Gardner et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci PLoS Genet 4 2008 e1000041
35. X.J. Zhang, W. Huang, S. Yang, L.D. Sun, F.Y. Zhang, and Q.X. Zhu et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21 Nat Genet 41 2009 205 210
36. J. Bowes, E. Flynn, P. Ho, B. Aly, A.W. Morgan, and H. Mazo-Ortega et al. Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis Ann Rheum Dis 69 2010 2199 2203
37. U. Huffmeier, X. Estivill, E. Riveira-Munoz, H. Traupe, J. Wendler, and J. Lohmann et al. Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to susceptibility to psoriatic arthritis in German patients Ann Rheum Dis 69 2010 876 878
38. H.F. Zheng, X.B. Zuo, W.S. Lu, Y. Li, H. Cheng, and K.J. Zhu et al. Variants in MHC, LCE and IL12B have epistatic effects on psoriasis risk in Chinese population J Dermatol Sci 61 2011 124 128
39. L. Xu, Y. Li, X. Zhang, H. Sun, D. Sun, and X. Jia et al. Deletion of LCE3C and LCE3B genes is associated with psoriasis in a northern Chinese population Br J Dermatol 165 2011 882 887
40. K.C. Duffin, I.C. Freeny, S.J. Schrodi, B. Wong, B.J. Feng, and R. Soltani-Arabshahi et al. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking J Invest Dermatol 129 2009 2777 2783
41. E. Ellinghaus, D. Ellinghaus, P.E. Stuart, R.P. Nair, S. Debrus, and J.V. Raelson et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 Nat Genet 42 2010 991 995
42. U. Hüffmeier, S. Uebe, A.B. Ekici, J. Bowes, E. Giardina, and E. Korendowych et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis Nat Genet 42 2010 996 999
43. J.E. Gudjonsson, and A. Johnston Current understanding of the genetic basis of psoriasis Expert Rev Clin Immunol 5 2009 433 443
44. R.P. Nair, J. Ding, K.C. Duffin, C. Helms, J.J. Voorhees, and G.G. Krueger et al. Psoriasis bench to bedside: genetics meets immunology Arch Dermatol 145 2009 462 464
45. K.C. Duffin, J. Woodcock, and G.G. Krueger Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association Dermatol Ther 23 2010 101 113
46. F. Capon, M.J. Bijlmakers, N. Wolf, M. Quaranta, U. Huffmeier, and M. Allen et al. Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene Hum Mol Genet 17 2008 1938 1945
47. Y. Li, W. Liao, M. Chang, S.J. Schrodi, N. Bui, and J.J. Catanese et al. Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22 J Invest Dermatol 129 2009 629 634
48. N. Wolf, M. Quaranta, N.J. Prescott, M. Allen, R. Smith, and A.D. Burden et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease J Med Genet 45 2008 114 116
49. M. Quaranta, A.D. Burden, C.E. Griffiths, J. Worthington, J.N. Barker, and R.C. Trembath et al. Differential contribution of CDKAL1 variants to psoriasis Genes Immun 10 2009 654 658
50. Genetic Analysis of Psoriasis Consortium, the Wellcome Trust Case Control Consortium 2 A. Strange, F. Capon, C.C. Spencer, J. Knight, M.E. Weale, and M.H. Allen et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 Nat Genet 42 2010 985 990
51. M.J. Bijlmakers, S.K. Kanneganti, J.N. Barker, R.C. Trembath, and F. Capon Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis Hum Mol Genet 20 2011 3129 3137
52. L.D. Sun, H. Cheng, Z.X. Wang, A.P. Zhang, P.G. Wang, and J.H. Xu et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population Nat Genet 42 2010 1005 1009
53. P.E. Stuart, R.P. Nair, E. Ellinghaus, J. Ding, T. Tejasvi, and J.E. Gudjonsson et al. Genome-wide association analysis identifies three psoriasis susceptibility loci Nat Genet 42 2010 1000 1004
54. J.C. Prinz Psoriasis vulgaris - a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis Clin Exp Dermatol 26 2001 326 332
55. B.J. Feng, L.D. Sun, R. Soltani-Arabshahi, A.M. Bowcock, R.P. Nair, and P. Stuart et al. Multiple loci within the major histocompatibility complex confer risk of psoriasis PLoS Genet 5 2009 e1000606
56. R. Pollock, V. Chandran, J. Barrett, L. Eder, F. Pellett, and C. Yao et al. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease Tissue Antigens 77 2011 554 561
57. E. Mallon, M. Bunce, H. Savoie, A. Rowe, R. Newson, and F. Gotch et al. HLA-C and guttate psoriasis Br J Dermatol 143 2000 1177 1182
58. B.S. Baker, J.D. Laman, A. Powles, L. van der Fits, J.S. Voerman, and M.J. Melief et al. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions J Pathol 209 2006 174 181
59. J.E. Gudjonsson, A. Johnston, H. Sigmundsdottir, and H. Valdimarsson Immunopathogenic mechanisms in psoriasis Clin Exp Immunol 135 2004 1 8
60. E.J. Hollox, U. Huffmeier, P.L. Zeeuwen, R. Palla, J. Lascorz, and D. Rodijk-Olthuis et al. Psoriasis is associated with increased beta-defensin genomic copy number Nat Genet 40 2008 23 25
61. Y. Suzuki, Y. Hamamoto, Y. Ogasawara, K. Ishikawa, Y. Yoshikawa, and T. Sasazuki et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris J Invest Dermatol 122 2004 1133 1136
62. S.J. Holm, K. Sakuraba, L. Mallbris, K. Wolk, M. Ståhle, and F.O. Sánchez Distinct HLA-C/KIR genotype profile associates with guttate psoriasis J Invest Dermatol 125 2005 721 730
63. F. Williams, A. Meenagh, C. Sleator, D. Cook, M. Fernandez-Vina, and A.M. Bowcock et al. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis Hum Immunol 66 2005 836 841
64. R. Płoski, W. Luszczek, P. Kuśnierczyk, P. Nockowski, M. Cisło, and P. Krajewski et al. A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis Hum Immunol 67 2006 521 526
65. Y.T. Chang, C.T. Chou, C.W. Yu, M.W. Lin, Y.M. Shiao, and C.C. Chen et al. Cytokine gene polymorphisms in Chinese patients with psoriasis Br J Dermatol 156 2007 899 905
66. S. Lippens, S. Lefebvre, B. Gilbert, M. Sze, M. Devos, and K. Verhelst et al. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis Cell Death Differ 18 2011 1845 1853
67. M. Matmati, P. Jacques, J. Maelfait, E. Verheugen, M. Kool, and M. Sze et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis Nat Genet 43 2011 908 912
68. F. Martin, and V.M. Dixit A20 edits ubiquitin and autoimmune paradigms Nat Genet 43 2011 822 823
69. M. Kool, G. van Loo, W. Waelput, S. de Prijck, F. Muskens, and M. Sze et al. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity Immunity 35 2011 82 96
70. L.E. Harrington, R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, and K.M. Murphy et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 2005 1123 1132
71. D.C. Newcomb, M.G. Boswell, W. Zhou, M.M. Huckabee, K. Goleniewska, and C.M. Sevin et al. Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production J Allergy Clin Immunol 127 2011 1006 1013 e1-4
72. S. Marrakchi, P. Guigue, B.R. Renshaw, A. Puel, X.Y. Pei, and S. Fraitag et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis N Engl J Med 365 2011 620 628
73. A. Onoufriadis, M.A. Simpson, A.E. Pink, P. di Meglio, C.H. Smith, and V. Pullabhatla et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis Am J Hum Genet 89 2011 432 437
74. E.W. Cowen, and R. Goldbach-Mansky DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name? Arch Dermatol 148 2012 381 384
75. C.T. Jordan, L. Cao, E.D. Roberson, K.C. Pierson, C.F. Yang, and C.E. Joyce et al. PSORS2 is due to mutations in CARD14 Am J Hum Genet 90 2012 784 795
76. C.T. Jordan, L. Cao, E.D. Roberson, S. Duan, C.A. Helms, and R.P. Nair et al. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis Am J Hum Genet 90 2012 796 808